Marksans Pharma Ltd
NSE:MARKSANS

Watchlist Manager
Marksans Pharma Ltd Logo
Marksans Pharma Ltd
NSE:MARKSANS
Watchlist
Price: 308.65 INR -0.16% Market Closed
Market Cap: 139.9B INR
Have any thoughts about
Marksans Pharma Ltd?
Write Note

Intrinsic Value

The intrinsic value of one MARKSANS stock under the Base Case scenario is 170.92 INR. Compared to the current market price of 308.65 INR, Marksans Pharma Ltd is Overvalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MARKSANS Intrinsic Value
170.92 INR
Overvaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Marksans Pharma Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MARKSANS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MARKSANS?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Marksans Pharma Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Marksans Pharma Ltd

Provide an overview of the primary business activities
of Marksans Pharma Ltd.

What unique competitive advantages
does Marksans Pharma Ltd hold over its rivals?

What risks and challenges
does Marksans Pharma Ltd face in the near future?

Has there been any significant insider trading activity
in Marksans Pharma Ltd recently?

Summarize the latest earnings call
of Marksans Pharma Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Marksans Pharma Ltd.

Provide P/S
for Marksans Pharma Ltd.

Provide P/E
for Marksans Pharma Ltd.

Provide P/OCF
for Marksans Pharma Ltd.

Provide P/FCFE
for Marksans Pharma Ltd.

Provide P/B
for Marksans Pharma Ltd.

Provide EV/S
for Marksans Pharma Ltd.

Provide EV/GP
for Marksans Pharma Ltd.

Provide EV/EBITDA
for Marksans Pharma Ltd.

Provide EV/EBIT
for Marksans Pharma Ltd.

Provide EV/OCF
for Marksans Pharma Ltd.

Provide EV/FCFF
for Marksans Pharma Ltd.

Provide EV/IC
for Marksans Pharma Ltd.

Show me price targets
for Marksans Pharma Ltd made by professional analysts.

What are the Revenue projections
for Marksans Pharma Ltd?

How accurate were the past Revenue estimates
for Marksans Pharma Ltd?

What are the Net Income projections
for Marksans Pharma Ltd?

How accurate were the past Net Income estimates
for Marksans Pharma Ltd?

What are the EPS projections
for Marksans Pharma Ltd?

How accurate were the past EPS estimates
for Marksans Pharma Ltd?

What are the EBIT projections
for Marksans Pharma Ltd?

How accurate were the past EBIT estimates
for Marksans Pharma Ltd?

Compare the revenue forecasts
for Marksans Pharma Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Marksans Pharma Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Marksans Pharma Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Marksans Pharma Ltd compared to its peers.

Compare the P/E ratios
of Marksans Pharma Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Marksans Pharma Ltd with its peers.

Analyze the financial leverage
of Marksans Pharma Ltd compared to its main competitors.

Show all profitability ratios
for Marksans Pharma Ltd.

Provide ROE
for Marksans Pharma Ltd.

Provide ROA
for Marksans Pharma Ltd.

Provide ROIC
for Marksans Pharma Ltd.

Provide ROCE
for Marksans Pharma Ltd.

Provide Gross Margin
for Marksans Pharma Ltd.

Provide Operating Margin
for Marksans Pharma Ltd.

Provide Net Margin
for Marksans Pharma Ltd.

Provide FCF Margin
for Marksans Pharma Ltd.

Show all solvency ratios
for Marksans Pharma Ltd.

Provide D/E Ratio
for Marksans Pharma Ltd.

Provide D/A Ratio
for Marksans Pharma Ltd.

Provide Interest Coverage Ratio
for Marksans Pharma Ltd.

Provide Altman Z-Score Ratio
for Marksans Pharma Ltd.

Provide Quick Ratio
for Marksans Pharma Ltd.

Provide Current Ratio
for Marksans Pharma Ltd.

Provide Cash Ratio
for Marksans Pharma Ltd.

What is the historical Revenue growth
over the last 5 years for Marksans Pharma Ltd?

What is the historical Net Income growth
over the last 5 years for Marksans Pharma Ltd?

What is the current Free Cash Flow
of Marksans Pharma Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Marksans Pharma Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Marksans Pharma Ltd

Current Assets 18.6B
Cash & Short-Term Investments 7.1B
Receivables 4.6B
Other Current Assets 7B
Non-Current Assets 8.2B
PP&E 6.8B
Intangibles 1B
Other Non-Current Assets 331.1m
Current Liabilities 3.9B
Accounts Payable 2.7B
Short-Term Debt 290.9m
Other Current Liabilities 924.8m
Non-Current Liabilities 2.3B
Long-Term Debt 1.9B
Other Non-Current Liabilities 360.3m
Efficiency

Earnings Waterfall
Marksans Pharma Ltd

Revenue
22.7B INR
Cost of Revenue
-10.6B INR
Gross Profit
12.1B INR
Operating Expenses
-8.1B INR
Operating Income
4B INR
Other Expenses
-702m INR
Net Income
3.3B INR

Free Cash Flow Analysis
Marksans Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MARKSANS Profitability Score
Profitability Due Diligence

Marksans Pharma Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive 3-Year Average ROE
Positive 3-Years Revenue Growth
61/100
Profitability
Score

Marksans Pharma Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

MARKSANS Solvency Score
Solvency Due Diligence

Marksans Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
97/100
Solvency
Score

Marksans Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MARKSANS Price Targets Summary
Marksans Pharma Ltd

Wall Street analysts forecast MARKSANS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MARKSANS is 290.19 INR with a low forecast of 267.65 INR and a high forecast of 319.2 INR.

Lowest
Price Target
267.65 INR
13% Downside
Average
Price Target
290.19 INR
6% Downside
Highest
Price Target
319.2 INR
3% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MARKSANS?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MARKSANS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MARKSANS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Marksans Pharma Ltd Logo
Marksans Pharma Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

139.9B INR

Dividend Yield

0.19%

Description

Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2002-04-03. The firm operates through the manufacture of pharmaceutical formulation segment. The firm is primarily engaged in the research, manufacturing and marketing of generic pharmaceutical formulations with three state-of-the-art facilities in India, the United Kingdom and the United States. The company marks its presence across different therapeutic areas in the region, such as pain management, diabetes, cough and cold, neurology, cardiovascular and hormonal treatment. The firm has a manufacturing facility for the manufacture of oral solid tablets, soft gelatin capsules and hard capsules in Goa. The company also manufactures non-sterile liquids, ointments and powder products and caters to the United Kingdom, West Africa and the Middle East, which is located in the United Kingdom. The firm has spread its facility to over 7000 square meters and manufactures tablets and capsules in the United States.

Contact

MAHARASHTRA
Mumbai
11th Floor Grandeur,, Off Veera Desai Road, Opp Gundecha Symphony,Andheri (W)
+912240012000
www.marksanspharma.com

IPO

2002-04-03

Employees

1 138

Officers

Non-Independent Executive Chairman & MD
Mr. Mark B. Saldanha
Chief Financial Officer
Mr. Jitendra M. Sharma
Director Operations
Mr. Vishal Bhargava
Company Secretary, Manager of Legal & Compliance Officer
Mr. Harshavardhan Panigrahi
Whole-Time Executive Non Independent Director
Mr. Varddhman Vikramaditya Jain
Senior Vice President of QC
Mr. Sunil K. Rane
Show More
Managing Director of Australia Operations
Mr. David Mohammed
Managing Director of UK Operations
Mr. Sathish Kumar
Chief Operating Officer of US Operations
Mr. Anjani Kumar
Show Less

See Also

Discover More
What is the Intrinsic Value of one MARKSANS stock?

The intrinsic value of one MARKSANS stock under the Base Case scenario is 170.92 INR.

Is MARKSANS stock undervalued or overvalued?

Compared to the current market price of 308.65 INR, Marksans Pharma Ltd is Overvalued by 45%.

Back to Top